Glanbia PLC
ISEQ:GL9
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
13.37
19.19
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Glanbia PLC
Glanbia PLC
Cost of Revenue
Glanbia PLC
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Glanbia PLC
ISEQ:GL9
|
Cost of Revenue
-$3.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Dole PLC
NYSE:DOLE
|
Cost of Revenue
-$7.6B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Greencore Group PLC
LSE:GNC
|
Cost of Revenue
-£1.3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-4%
|
|
|
Kerry Group PLC
ISEQ:KRZ
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Glanbia PLC
Glance View
Glanbia PLC, with roots firmly embedded in the Emerald Isle, is a testament to the evolution and innovation in the global food industry. Originally emerging from the dairy cooperatives of Ireland, Glanbia has masterfully transformed itself from a local dairy operation into a global nutritional powerhouse. At the heart of its operations is a deep-seated commitment to nutrition – crafting products that cater to the growing global demand for healthier, functional foods. The company's business model is intricately woven around two core divisions: Glanbia Performance Nutrition, which crafts and supplies a diverse portfolio of performance nutrition products, and Glanbia Nutritionals, which delivers bespoke nutritional solutions through its comprehensive dairy and non-dairy ingredients. These synergistic divisions allow Glanbia to tap into and steer multiple nodes of the health and wellness megatrend. The financial heartbeat of Glanbia comes from its ability to marry science with nutritional innovation. By leveraging advanced research and development capabilities, the company consistently innovates, ensuring its offerings remain at the cutting edge of consumer trends. Glanbia Performance Nutrition's leading brands like Optimum Nutrition and SlimFast cater to fitness enthusiasts and health-conscious consumers, translating into robust sales globally. Meanwhile, Glanbia Nutritionals' sophisticated ingredients and solutions, utilized by leading brands in the food and beverage industry, underpin a reliable revenue stream. This dual-engine strategy ensures Glanbia not only meets current market demands but is also strategically positioned to adapt to the fluid dynamics of the health-focused consumer marketplace. Through this, Glanbia PLC fortifies its standing as not just a company, but a vital participant in the global narrative of nutritional well-being.
See Also
What is Glanbia PLC's Cost of Revenue?
Cost of Revenue
-3.3B
USD
Based on the financial report for Jun 29, 2024, Glanbia PLC's Cost of Revenue amounts to -3.3B USD.
What is Glanbia PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-4%
Over the last year, the Cost of Revenue growth was 29%. The average annual Cost of Revenue growth rates for Glanbia PLC have been 12% over the past three years , -4% over the past five years .
You don't have any saved screeners yet
